LD-2 disclosure · 3rd Quarter - Report
PRIME THERAPEUTICS
Client
- Location
- Minnesota · United States of America
Registrant
- Description
- Pharmacy Benefit Management
- Location
- Eagan, Minnesota, United States of America
Lobbying activities
2 issuesHealth Issues
S. 954: Affordable Insulin Now Act of 2023, provisions related to cost-sharing for insulin. S. 1269: INSULIN Act of 2023, provisions related to cost-sharing for insulin. H.R. 5378: The Lower Costs, More Transparency Act, provisions related to PBM transparency. S. 2305: Biosimilar Red Tape Elimination Act, provisions related to addressing biosimilar interchangeability. H.R. 4507: Transparency in Coverage Act of 2023, provisions related to PBM transparency. H.R. 4527: Health DATA Act provisions related to plan fiduciaries access to data. H.R. 5378: The Lower Costs, More Transparency Act, Sections 105, 106, 109, 110, 202, 401, 402 and 403, provisions related to PBM transparency and disclosure. S. 127: PBM Transparency Act of 2023, provisions related to PBM disclosure and contracting arrangements. S. 1339: PBM Reform Act, provisions related to PBM disclosure and contracting arrangements.
LobbyistsJULIE CAROL CANTOR-WEINBERG
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
H.R. 5372: Expanding Seniors Access and Lost Cost Medicines Act of 2023, provisions to set drug price cost-sharing. H.R. 5385: Medicare PBM Accountability Act, provisions related to PBM reporting requirements. H.R. 5386: Cutting Coupons Act, provisions related to cost-sharing requirements for low-income Medicare beneficiaries. H.R. 3284: Providers & Payers COMPETE Act, provisions related to consolidation. S. 2973: Modernizing and Ensuring PBM Accountability Act, provisions related to PBM regulation.
LobbyistsJULIE CAROL CANTOR-WEINBERG
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)